JACC
HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
 QUICK SEARCH:   [advanced]


     


J Am Coll Cardiol, 1995; 25:1354-1361
© 1995 by the American College of Cardiology Foundation
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Manning, W.
Right arrow Articles by Douglas, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Manning, W.
Right arrow Articles by Douglas, P.

Transesophageal echocardiographically facilitated early cardioversion from atrial fibrillation using short-term anticoagulation: final results of a prospective 4.5-year study

WJ Manning, DI Silverman, CS Keighley, P Oettgen, and PS Douglas

Charles A. Dana Research Institute, Beth Israel Hospital, Boston, Massachusetts 02215, USA.

OBJECTIVES. We sought to validate the safety of transesophageal echocardiographically guided early cardioversion in conjunction with short-term anticoagulation as a strategy for guiding early cardioversion in hospitalized patients with atrial fibrillation. BACKGROUND. Because atrial thrombi are poorly seen by conventional imaging techniques, several weeks of prophylactic anticoagulation is routinely prescribed before cardioversion. Transesophageal echocardiography is a superior test for identifying atrial thrombi; preliminary feasibility studies have supported its use to guide early cardioversion for patients in whom no thrombus is observed, but safety has not been validated in any large series. METHODS. All patients admitted to hospital with atrial fibrillation during a 4.5-year period were screened. The inclusion criterion was a clinical duration of atrial fibrillation > 2 days or of unknown duration. Patients received anticoagulation with heparin/warfarin and underwent conventional transthoracic echocardiography followed by transesophageal study. Patients in whom transesophageal echocardiography revealed no atrial thrombus underwent pharmacologic or electrical cardioversion followed by warfarin therapy for 1 month. Cardioversion was deferred in patients with evidence of atrial thrombi, and they received prolonged warfarin treatment. RESULTS. Two hundred thirty-three patients (86% of those eligible) agreed to participate, and 230 underwent transesophageal echocardiography. Transesophageal echocardiography identified 40 atrial thrombi (left atrium 34, right atrium 6) in 34 patients (15%). One hundred eighty-six (95%) of 196 patients without thrombi had successful cardioversion to sinus rhythm, all without prolonged anticoagulation, and none (0%, 95% confidence interval 0% to 1.6%) experienced a clinical thromboembolic event. Eighteen patients with atrial thrombi underwent uneventful cardioversion after prolonged anticoagulation. CONCLUSIONS. Compared with smaller series that have shown only feasibility, this large prospective and consecutive study of patients undergoing transesophageal echocardiographically facilitated early cardioversion in conjunction with short-term anticoagulation validates the safety of this strategy. This treatment algorithm has a safety profile similar to conventional therapy and minimizes both the period of anticoagulation and the overall duration of atrial fibrillation.


This article has been cited by other articles:


Home page
CirculationHome page
2006 WRITING COMMITTEE MEMBERS, R. O. Bonow, B. A. Carabello, K. Chatterjee, A. C. de Leon Jr, D. P. Faxon, M. D. Freed, W. H. Gaasch, B. W. Lytle, R. A. Nishimura, et al.
2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons
Circulation, October 7, 2008; 118(15): e523 - e661.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
R. O. Bonow, B. A. Carabello, K. Chatterjee, A. C. de Leon Jr, D. P. Faxon, M. D. Freed, W. H. Gaasch, B. W. Lytle, R. A. Nishimura, P. T. O'Gara, et al.
2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease) Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons
J. Am. Coll. Cardiol., September 23, 2008; 52(13): e1 - e142.
[Full Text] [PDF]


Home page
ChestHome page
D. E. Singer, G. W. Albers, J. E. Dalen, M. C. Fang, A. S. Go, J. L. Halperin, G. Y. H. Lip, and W. J. Manning
Antithrombotic Therapy in Atrial Fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)
Chest, June 1, 2008; 133(6_suppl): 546S - 592S.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
A. L. Klein, S. E. Jasper, W. E. Katz, J. F. Malouf, L. A. Pape, M. F. Stoddard, C. Apperson-Hansen, E. A. Lieber, and The ACUTE II Steering and Publications Committee F
The use of enoxaparin compared with unfractionated heparin for short-term antithrombotic therapy in atrial fibrillation patients undergoing transoesophageal echocardiography-guided cardioversion: Assessment of Cardioversion Using Transoesophageal Echocardiography (ACUTE) II randomized multicentre study
Eur. Heart J., December 1, 2006; 27(23): 2858 - 2865.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
Writing Committee Members, V. Fuster, L. E. Ryden, D. S. Cannom, H. J. Crijns, A. B. Curtis, K. A. Ellenbogen, J. L. Halperin, J.-Y. Le Heuzey, G. N. Kay, et al.
ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: full text: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society
Europace, September 1, 2006; 8(9): 651 - 745.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
V. Fuster, L. E. Ryden, D. S. Cannom, H. J. Crijns, A. B. Curtis, K. A. Ellenbogen, J. L. Halperin, J.-Y. Le Heuzey, G. N. Kay, J. E. Lowe, et al.
ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society
J. Am. Coll. Cardiol., August 15, 2006; 48(4): e149 - e246.
[Full Text] [PDF]


Home page
CirculationHome page
V. Fuster, L. E. Ryden, D. S. Cannom, H. J. Crijns, A. B. Curtis, K. A. Ellenbogen, J. L. Halperin, J.-Y. Le Heuzey, G. N. Kay, J. E. Lowe, et al.
ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society
Circulation, August 15, 2006; 114(7): e257 - e354.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
R. O. Bonow, B. A. Carabello, K. Chatterjee, A. C. de Leon Jr, D. P. Faxon, M. D. Freed, W. H. Gaasch, B. W. Lytle, R. A. Nishimura, P. T. O'Gara, et al.
ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease) Developed in Collaboration With the Society of Cardiovascular Anesthesiologists Endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons
J. Am. Coll. Cardiol., August 1, 2006; 48(3): e1 - e148.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
R. O. Bonow, B. A. Carabello, K. Chatterjee, A. C. de Leon Jr, D. P. Faxon, M. D. Freed, W. H. Gaasch, B. W. Lytle, R. A. Nishimura, P. T. O'Gara, et al.
ACC/AHA 2006 Practice Guidelines for the Management of Patients With Valvular Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease) Developed in Collaboration With the Society of Cardiovascular Anesthesiologists Endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons
J. Am. Coll. Cardiol., August 1, 2006; 48(3): 598 - 675.
[Full Text] [PDF]


Home page
HeartHome page
A Maltagliati, C A Galli, G Tamborini, A Calligaris, E Doria, R Salehi, and M Pepi
Usefulness of transoesophageal echocardiography before cardioversion in patients with atrial fibrillation and different anticoagulant regimens
Heart, July 1, 2006; 92(7): 933 - 938.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
M. Strandberg, M.J. P. Raatikainen, M. Niemela, M. Luotolahti, J. Hartiala, and K.E. J. Airaksinen
Clinical practicality and predictive value of transoesophageal echocardiography in early cardioversion of atrial fibrillation
Europace, June 1, 2006; 8(6): 408 - 412.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
E. Spuentrup, B. Fausten, S. Kinzel, A. J. Wiethoff, R. M. Botnar, P. B. Graham, S. Haller, M. Katoh, E. C. Parsons Jr, W. J. Manning, et al.
Molecular Magnetic Resonance Imaging of Atrial Clots in a Swine Model
Circulation, July 19, 2005; 112(3): 396 - 399.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
O A Obel, L Luddington, N Maarouf, K Aytemir, C Ekwall, M Malik, and A J Camm
Effects of ventricular rate and regularity on the velocity and magnitude of left atrial appendage flow in atrial fibrillation
Heart, June 1, 2005; 91(6): 764 - 768.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
D. E. Singer, G. W. Albers, J. E. Dalen, A. S. Go, J. L. Halperin, and W. J. Manning
Antithrombotic Therapy in Atrial Fibrillation: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy
Chest, September 1, 2004; 126(3_suppl): 429S - 456S.
[Abstract] [Full Text] [PDF]


Home page
Eur J EchocardiogrHome page
J.A Sallach and A.L Klein
Subtherapeutic anticoagulation: the bane of conventional anticoagulation for cardioversion of atrial fibrillation
Eur J Echocardiogr, August 1, 2004; 5(4): 239 - 242.
[Full Text] [PDF]


Home page
Eur J EchocardiogrHome page
G Corrado, S Beretta, L Sormani, G Tadeo, G Foglia-Manzillo, L.M Tagliagambe, and M Santarone
Prevalence of atrial thrombi in patients with atrial fibrillation/flutter and subtherapeutic anticoagulation prior to cardioversion
Eur J Echocardiogr, August 1, 2004; 5(4): 257 - 261.
[Abstract] [Full Text] [PDF]


Home page
J. Gerontol. A Biol. Sci. Med. Sci.Home page
W. S. Aronow
Management of the Older Person With Atrial Fibrillation
J. Gerontol. A Biol. Sci. Med. Sci., June 1, 2002; 57(6): M352 - 363.
[Abstract] [Full Text]


Home page
Eur Heart JHome page
Guidelines for the management of patients with atrial fibrillation. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to develop guidelines for the management of patients with atrial fibrillation) developed in collaboration with the North American Society of Pacing and Electrophysiology
Eur. Heart J., October 2, 2001; 22(20): 1852 - 1923.
[PDF]


Home page
J Am Coll CardiolHome page
V. Fuster, L. E. Ryden, R. W. Asinger, D. S. Cannom, H. J. Crijns, R. L. Frye, J. L. Halperin, G. N. Kay, W. W. Klein, S. Levy, et al.
ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the North American Society of Pacing and Electrophysiology
J. Am. Coll. Cardiol., October 1, 2001; 38(4): 1266 - 1266.
[Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
J. Hirsh, S. S. Anand, J. L. Halperin, and V. Fuster
Guide to Anticoagulant Therapy: Heparin : A Statement for Healthcare Professionals From the American Heart Association
Arterioscler. Thromb. Vasc. Biol., July 1, 2001; 21 (7): e9 - e9.
[Full Text] [PDF]


Home page
CirculationHome page
J. Hirsh, S. S. Anand, J. L. Halperin, and V. Fuster
Guide to Anticoagulant Therapy: Heparin : A Statement for Healthcare Professionals From the American Heart Association
Circulation, June 19, 2001; 103(24): 2994 - 3018.
[Full Text] [PDF]


Home page
Eur Heart JHome page
G Corrado, A Sgalambro, A Mantero, F Gentile, M Gasparini, R Bufalino, A Morabito, G Trocino, R Schiavina, S Mandorla, et al.
Thromboembolic risk in atrial flutter. The FLASIEC (FLutterAtrialeSocietaIaliana diEcografiaCardiovascolare) multicentre study
Eur. Heart J., June 2, 2001; 22(12): 1042 - 1051.
[Abstract] [PDF]


Home page
NEJMHome page
A. L. Klein, R. A. Grimm, R. D. Murray, C. Apperson-Hansen, R. W. Asinger, I. W. Black, R. Davidoff, R. Erbel, J. L. Halperin, D. A. Orsinelli, et al.
Use of Transesophageal Echocardiography to Guide Cardioversion in Patients with Atrial Fibrillation
N. Engl. J. Med., May 10, 2001; 344(19): 1411 - 1420.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
R. H. Falk
Atrial Fibrillation
N. Engl. J. Med., April 5, 2001; 344(14): 1067 - 1078.
[Full Text] [PDF]


Home page
Eur Heart JHome page
S. Kamath and G.Y.H. Lip
Cardioversion of atrial fibrillation or flutter: a 'stunning' problem
Eur. Heart J., March 2, 2001; 22(6): 520 - 521.
[PDF]


Home page
J Am Coll CardiolHome page
A. L. Klein, R. D. Murray, and R. A. Grimm
Role of transesophageal echocardiography-guided cardioversion of patients with atrial fibrillation
J. Am. Coll. Cardiol., March 1, 2001; 37(3): 691 - 704.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
A Roijer, J Eskilsson, and B Olsson
Transoesophageal echocardiography-guided cardioversion of atrial fibrillation or flutter. Selection of a low-risk group for immediate cardioversion
Eur. Heart J., May 2, 2000; 21(10): 837 - 847.
[Abstract] [PDF]


Home page
J Am Coll CardiolHome page
M. M. Scheinman
Mechanisms of atrial fibrillation: is a cure at hand?
J. Am. Coll. Cardiol., May 1, 2000; 35(6): 1687 - 1692.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
A.U Khand, A.C Rankin, G.C Kaye, and J.G.F Cleland
Systematic review of the management of atrial fibrillation in patients with heart failure
Eur. Heart J., April 2, 2000; 21(8): 614 - 632.
[Abstract] [PDF]


Home page
EuropaceHome page
G. Corrado, M. Santarone, S. Beretta, G. Tadeo, L.M. Tagliagambe, G. Foglia-Manzillo, M. Spata, E. Miglierina, F. Acquati, and M. Santarone
Early cardioversion of atrial fibrillation and atrial flutter guided by transoesophageal echocardiography: A single centre 8{middle dot}5-year experience
Europace, January 1, 2000; 2(2): 119 - 126.
[Abstract] [PDF]


Home page
HeartHome page
M J Weigner, S E Katz, P S Douglas, and W J Manning
Left atrial appendage anatomy and function: short term response to sustained atrial fibrillation
Heart, November 1, 1999; 82(5): 555 - 558.
[Abstract] [Full Text]


Home page
CirculationHome page
H.-W. M. Breuer, W. J. Manning, and D. I. Silverman
Spontaneous Echo Contrast and Atrial Fibrillation • Response
Circulation, February 23, 1999; 99 (7): 975 - 978.
[Full Text] [PDF]


Home page
ChestHome page
G. Corrado, G. Tadeo, S. Beretta, L. M. Tagliagambe, G. F. Manzillo, M. Spata, and M. Santarone
Atrial Thrombi Resolution After Prolonged Anticoagulation in Patients With Atrial Fibrillation: A Transesophageal Echocardiographic Study
Chest, January 1, 1999; 115(1): 140 - 143.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
D. I. Silverman and W. J. Manning
Role of Echocardiography in Patients Undergoing Elective Cardioversion of Atrial Fibrillation
Circulation, August 4, 1998; 98(5): 479 - 486.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J. P. Veinot, P. J. Harrity, F. Gentile, B. K. Khandheria, K. R. Bailey, J. T. Eickholt, J. B. Seward, A. J. Tajik, and W. D. Edwards
Anatomy of the Normal Left Atrial Appendage : A Quantitative Study of Age-Related Changes in 500 Autopsy Hearts: Implications for Echocardiographic Examination
Circulation, November 4, 1997; 96(9): 3112 - 3115.
[Abstract] [Full Text]


Home page
CirculationHome page
W. N. Irani, P. A. Grayburn, and I. Afridi
Prevalence of Thrombus, Spontaneous Echo Contrast, and Atrial Stunning in Patients Undergoing Cardioversion of Atrial Flutter: A Prospective Study Using Transesophageal Echocardiography
Circulation, February 18, 1997; 95(4): 962 - 966.
[Abstract] [Full Text]


Home page
CirculationHome page
E. N. Prystowsky, D. W. Benson Jr, V. Fuster, R. G. Hart, G. N. Kay, R. J. Myerburg, G. V. Naccarelli, and D. G. Wyse
Management of Patients With Atrial Fibrillation : A Statement for Healthcare Professionals From the Subcommittee on Electrocardiography and Electrophysiology, American Heart Association
Circulation, March 15, 1996; 93(6): 1262 - 1277.
[Full Text]


Home page
Ann. Thorac. Surg.Home page
B. D. Lindsay
Obliteration of the Left Atrial Appendage: A Concept Worth Testing
Ann. Thorac. Surg., February 1, 1996; 61(2): 515 - 515.
[Full Text]


Home page
Ann. Thorac. Surg.Home page
J. A. Odell, J. L. Blackshear, E. Davies, W. J. Byrne, C. F. Kollmorgen, W. D. Edwards, and T. A. Orszulak
Thoracoscopic Obliteration of the Left Atrial Appendage: Potential for Stroke Reduction?
Ann. Thorac. Surg., February 1, 1996; 61(2): 565 - 569.
[Abstract] [Full Text]


Home page
NEJMHome page
H. G. Bogren, A. M. Lam, Y. Enokawa, Y. Seko, Y. Yazaki, W. G. Daniel, and A. Mugge
Transesophageal Echocardiography
N. Engl. J. Med., October 26, 1995; 333(17): 1153 - 1154.
[Full Text]




HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
Copyright © 1995 by the American College of Cardiology Foundation.